Related Articles

  • Assisted reproductive technology use in the United States: a population assessment
    Fertility and SterilityVol. 112Issue 6
    • In Brief
      To study social and demographic differentiation of assisted reproduction technology (ART) use at the population level in the United States.
    • Full-Text
    • PDF
  • Assisted reproductive technology and perinatal outcomes: conventional versus discordant-sibling design
    Fertility and SterilityVol. 106Issue 3
    • In Brief
      To compare risks of adverse perinatal outcomes between assisted reproductive technology (ART) and naturally conceived singleton births using a dual design approach.
    • Full-Text
    • PDF
  • Society for Assisted Reproductive Technology advertising guidelines: how are member clinics doing?
    Fertility and Sterility
    • In Brief
      To examine whether Society for Assisted Reproductive Technology (SART) member in vitro fertilization (IVF) centers adhere to the Society’s new advertising policy, updated in January 2018, and evaluate other services advertised by region, insurance mandate and university affiliation status. Historically, a large percentage of IVF clinics have not adhered to SART guidelines for IVF clinic website advertising and have had variability in how financial incentives and other noncore fertility services are advertised.
    • Full-Text
    • PDF
  • Fertility clinic advertising in the United States: is the Society for Assisted Reproductive Technology oversight of advertising policy effective?
    Fertility and Sterility
    • In Brief
      The Society for Assisted Reproductive Technology (SART) is a nonprofit organization that was founded in 1985 with an initial goal of establishing a national registry of in vitro fertilization (IVF) procedures and outcomes. The purpose of the registry was to determine clinical effectiveness, safety, and quality of care. The Society for Assisted Reproductive Technology subsequently developed the SART Clinical Outcome Reporting System, perhaps the first such registry in the United States. In vitro fertilization clinic specific outcome data voluntarily were submitted to SART, combined into a national report, and published annually since 1988 (1).
    • Full-Text
    • PDF
  • Contributions to prematurity of maternal health conditions, subfertility, and assisted reproductive technology
    Fertility and SterilityVol. 114Issue 4
    • In Brief
      To determine the maternal demographic, health, and fertility variables underlying prematurity.
    • Full-Text
    • PDF
  • Perinatal outcomes among singletons after assisted reproductive technology with single-embryo or double-embryo transfer versus no assisted reproductive technology
    Fertility and SterilityVol. 107Issue 4
    • In Brief
      To examine outcomes of singleton pregnancies conceived without assisted reproductive technology (non-ART) compared with singletons conceived with ART by elective single-embryo transfer (eSET), nonelective single-embryo transfer (non-eSET), and double-embryo transfer with the establishment of 1 (DET −1) or ≥2 (DET ≥2) early fetal heartbeats.
    • Full-Text
    • PDF
  • Impact of assisted reproductive technology on the incidence of multiple-gestation infants: a population perspective
    Fertility and SterilityVol. 103Issue 1
    • In Brief
      To study the value of a population view in assessing assisted reproductive technology (ART) multiple-gestation infants.
    • Full-Text
    • PDF
  • Endometriosis-related infertility: assisted reproductive technology has no adverse impact on pain or quality-of-life scores
    Fertility and SterilityVol. 105Issue 4
    • In Brief
      To evaluate the impact of assisted reproduction technology (ART) on painful symptoms and quality of life (QoL) in women who have endometriosis as compared with disease-free women.
    • Full-Text
    • PDF
  • Assessing the use of assisted reproductive technology in the United States by non–United States residents
    Fertility and SterilityVol. 108Issue 5
    • In Brief
      To study cross-border reproductive care (CBRC) by assessing the frequency and nature of assisted reproductive technology (ART) care that non-U.S. residents receive in the United States.
    • Full-Text
    • PDF
  • Health of adults aged 22 to 35 years conceived by assisted reproductive technology
    Fertility and SterilityVol. 112Issue 1
    • In Brief
      To determine the health outcomes for adults aged 22–35 years old who were conceived via assisted reproduction technology (ART) compared with adults of the same age conceived without use of ART.
    • Full-Text
    • PDF